Jan 20, 2016 8:04 PM by News Staff
Dozens of makers of medicines and diagnostic tests have joined together in an unprecedented effort to tackle "superbugs" - infections that increasingly don't respond to drugs and threaten millions of people in countries rich and poor.
Altogether, 74 drugmakers, 11 makers of diagnostic tests and nine industry groups have signed an agreement to work together and with governments to prevent and improve treatment of drug-resistant infections. They plan to announce the agreement Thursday at the World Economic Forum in Davos, Switzerland.
The effort is sorely needed. Many common infections no longer respond to conventional drugs, mainly due to overuse of antibiotics, few new drugs to fight bacteria, viruses, parasites and fungi, and declining industry research in the field. By 2050, superbugs are expected to kill about 10 million people annually.
Copyright 2016 The Associated Press. All rights reserved.